AFP and hepatocellular carcinoma: The current study suggested that HCC patients who met the “Up-to-seven” criteria and AFP of < 1000 ng/ml had better survival than those who met the Milan criteria, allowing 28.9% (13/45) of patients who did not meet the Milan criteria to benefit from OLT.